Core Viewpoint - Haizheng Pharmaceutical (600267.SH) has successfully completed the Self-GRAS scientific evaluation for its product 1,4-butanedisulfonic acid adenosylmethionine, receiving unanimous approval from the expert panel, thus achieving Self-GRAS certification in the U.S. market [1] Group 1 - The product 1,4-butanedisulfonic acid adenosylmethionine has passed the Self-GRAS certification, indicating it has undergone a scientific evaluation process and is now recognized as safe for use in the U.S. market [1] - This certification allows the product to be sold and used as a safe dietary ingredient in the U.S. and other international markets that recognize U.S. GRAS certification [1] - The successful certification is expected to enrich the company's profit structure and lay a crucial foundation for the global expansion of its dietary business [1]
海正药业:1,4-丁二磺酸腺苷蛋氨酸通过美国Self-GRAS 认证